Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Compounds having selective activity for Retinoid X Receptors, and means for modulation of processes mediated by Retinoid X Receptors

a technology of retinoid x receptor and selective activity, which is applied in the field of compounds having selective activity for retinoid x receptors, can solve the problems of irritation of the treated tissues, the wide spectrum of pharmacological actions of retinoic acid is not reproduced in full by all bioactive synthetic retinoids, and the use of retinoids is associated with a number of significant side effects, so as to achieve the effect of modulating processes

Inactive Publication Date: 2006-05-18
EISAI INC
View PDF1 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0014] The present invention is directed to compounds, compositions, and methods for modulating processes mediated by one or more Retinoid X Receptors. More particularly, the invention relates to compounds which selectively or preferentially activate Retinoid X Receptors, in comparison to Retinoic Acid Receptors. These compounds selectively modulate processes mediated by Retinoid X Receptors. Accordingly, the invention also relates to methods for modulating processes selectively mediated

Problems solved by technology

However, the broad spectrum of pharmacological actions of retinoic acid is not reproduced in full by all bioactive synthetic retinoids.
Use of the retinoids is associated with a number of significant side effects.
The most serious of these is that, as a class, they are among the most potent teratogens known.
Other side effects include irritation of the tissues treated, which can be so severe that patients cannot tolerate treatment.
This has been a complicated task, however, since the assays available to investigators have been bioassays, carried out either in intact animals or in isolated tissues.
Technical constraints have often dictated the use of different small animal species for different assays.
Interpretation of results has been complicated by possible pharmacokinetic and metabolic effects and possible species differences in the receptors involved.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Compounds having selective activity for Retinoid X Receptors, and means for modulation of processes mediated by Retinoid X Receptors
  • Compounds having selective activity for Retinoid X Receptors, and means for modulation of processes mediated by Retinoid X Receptors
  • Compounds having selective activity for Retinoid X Receptors, and means for modulation of processes mediated by Retinoid X Receptors

Examples

Experimental program
Comparison scheme
Effect test

example 1

Preparation of compound 3 where R1, R2, R3, R4 and R5 are methyl, R′ and R″ are oxo, and X=COOMe

[0100] To 7 gm (34.7 mmol) of 1,1,4,4,6-pentamethyl-1,2,3,4-tetrahydronaphthalene and 6 gm (33.3 mmol) of mono-methyl teraphthalate in 200 mL of CH2Cl2 was added 8 g (38.8 mmol) of PCl5. The reaction boiled vigorously and turned clear within 10 min. After stirring for an additional 1 h, 6 g (43.5 mmol) of AlCl3 was added in 1 g portions over 15 min. and the reaction was allowed to stir overnight. The mixture was poured into 300 mL of 20% aqueous HCl and extracted with 5% EtoAc-hexanes, dried (MgSO4), concentrated, and crystallized from MeOH to give ca. 6 gm (16.5 mmol) of methyl ester 3. 1HNMR (CD3 OCD3) δ 1.20 (s, 2(CH3)), 1.35 (s, 2(CH3)), 1.75 (s, 2(CH2)), 2.31 (s, CH3), 3.93 (s, COOCH3), 7.21 (s, Ar—CH), 7.23 (s, ArCH), 7.85 (d, J=8 Hz, Ar-2(CH)), 8.18 (d, J=8 Hz, Ar-2(CH)).

example 2

Preparation of compound 4 where R1, R2, R3, R4 and R5 are methyl, R′ and R″ are oxo, and X=COOH (3-methyl-TTNCB)

[0101] To 6 gm (16.5 mmol) of methyl ester 3 suspended in 100 mL of MeOH was added 50 mL of 5N aqueous KOH. The mixture was heated under reflux for 1 h, cooled, acidified (20% aqueous HCl) and the organics extracted with EtOAc. After drying (MgSO4), the product was concentrated and precipitated from 1:4 EtOAc-hexanes to give ca. 5 g (14.3 mmol) of acid 4. 1HNMR (CD3OCD3) δ 1.20 (s, 2(CH3)), 1.35 (s, 2(CH3)), 1.75 (s, 2(CH2)), 2.31 (s, CH3), 7.21 (s, Ar—CH), 7.23 (s, Ar—CH), 7.91 (d, J=8 Hz, Ar-2(CH)), 8.21 (d, J=8 Hz, Ar-2(CH)).

example 3

Preparation of compound 5 where R1, R2, R3, R4 and R5 are methyl, R′=H and R″=OH, and X=COOH (3-methyl-TTNHMB)

[0102] To a 1:1 THF-MeOH solution containing 1 g (2.86 mmol) of ketone 4 was added 100 mg of NaBH4. The mixture was heated to 50° C. for 10 min., cooled, acidified (20% aqueous HCl), and the organics extracted (EtOAc). After drying (MgSO4), the product was concentrated and precipitated from 1:3 EtOAc-hexanes to give 550 mg (1.56 mmol) of the alcohol 5. 1HNMR (CD3OCD3) δ 1.20 (s, CH3)), 1.22 (s,(CH3)), 1.22 (s, 2(CH3)), 1.65 (s, 2(CH2)), 2.21 (s, CH3), 6.00 (s, —CHOH—), 7.09 (s, Ar—CH), 7.41 (s, Ar—CH), 7.53 (d, J=8 Hz, Ar-2(CH)), 8.01 (d, J=8 Hz, Ar-2(CH)).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Molar densityaaaaaaaaaa
Molar densityaaaaaaaaaa
Molar densityaaaaaaaaaa
Login to View More

Abstract

Compounds, compositions, and methods for modulating processes mediated by Retinoid X Receptors using retinoid-like compounds which have activity selective for members of the subclass of Retinoid X Receptors (RXRs), in preference to members of the subclass of Retinoic Acid Receptors (RARs). Examples of such compounds are bicyclic benzyl, pyridinyl, thiophene, furanyl, and pyrrole derivatives. The disclosed methods employ compounds for modulating processes selectively mediated by Retinoid X Receptors.

Description

RELATED APPLICATIONS [0001] This is a continuation of application Ser. No. 08 / 141,496, filed Oct. 22, 1993, which is a continuation-in-part of the application Ser. No. 08 / 052,051 filed on Apr. 21, 1993 now abandoned, which is a continuation-in-part of the application Ser. No. 08 / 027,747 filed on Mar. 5, 1993 now abandoned, which is a continuation-in-part of application Ser. No. 08 / 003,223 filed on Jan. 11, 1993 now abandoned, which is a continuation-in-part of application Ser. No. 07 / 944,783 filed on Sep. 11, 1992 now abandoned, which is a continuation-in-part of application Ser. No. 07 / 872,707 filed Apr. 22, 1992 now abandoned, whose entire disclosures are incorporated herein by reference. Benefit of priority under 35 U.S.C. §120 is claimed to these applications.FIELD OF THE INVENTION [0002] This invention relates to intracellular receptors and ligands therefor. More specifically, this invention relates to compounds having selective activity for specific retinoic acid receptors, an...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/44A61K31/195G01N33/566A61K31/00A61K31/165A61K31/19A61K31/235A61K31/275A61K31/336A61K31/35A61K31/352A61K31/38A61K31/381A61K31/41A61K31/4418A61K31/455A61P3/02A61P3/06A61P17/00A61P35/00A61P43/00C07C63/331C07C63/36C07C63/49C07C63/66C07C63/72C07C63/74C07C65/17C07C65/19C07C65/34C07C65/36C07C65/40C07C69/76C07C233/66C07C233/75C07C233/81C07C235/84C07C251/24C07C251/48C07C251/58C07C251/60C07C261/04C07C325/02C07D213/78C07D213/79C07D213/80C07D257/04C07D303/02C07D303/38C07D307/68C07D311/58C07D333/38C07D333/40C07D405/04
CPCC07C63/49C07C63/66C07C63/72C07C65/19C07C65/36C07C65/40C07C69/76C07C233/66C07C233/75C07C233/81C07C235/84C07C2102/08C07C2102/10C07D213/79C07D213/80C07D257/04C07D303/38C07D307/68C07D311/58C07D333/38C07D405/04A61P3/02A61P3/06A61P17/00A61P35/00A61P43/00C07C2602/08C07C2602/10
Inventor BOEHM, MARCUS F.HEYMAN, RICHARD A.
Owner EISAI INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com